PMDL — Pace Medical Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -24.36% | ||
| Operating Margin | -12.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006E | 2007E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.55 | 1.21 | 1.32 | 1.22 | 1.45 | n/a | n/a | 4.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pace Medical, Inc. is a medical device company. The Company designs and markets a complete line of temporary cardiac pacing products to meet the expanding needs of the medical profession worldwide. The Company’s products include both single and dual-chamber temporary cardiac pacemakers, a dual-chamber pacing analyzer, autoclavable temporary pacemaker extension and surgical cables, disposable surgical extension cables and related accessories. The Company’s single-chamber temporary cardiac pacemakers include the Bedside model which attaches to the patient’s bedrail and the Mini-Pacer product line which enable the patient to remain ambulatory during treatment. The Company’s MICRO-PACE, dual-chamber temporary cardiac pacemaker, is software programmable and capable of multi-parameter, multi-mode operation. It has the ability to sense and pace at high rates in the DDD mode; thereby, restoring A-V synchrony and improving cardiac output.
Directors
- Ralph Hanson CHM (81)
- Steven Hanson CEO (56)
- Drusilla Hays VPR (60)
- Derrick Ebden DRC (59)
- George Harrington DRC (73)
- Last Annual
- December 31st, 2005
- Last Interim
- December 31st, 2005
- Incorporated
- May 29th, 1985
- Public Since
- June 16th, 1992
- No. of Employees
- 12
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 3,354,870
- Address
- 310 South Street, PLAINVILLE, 02762
- Web
- Phone
- +1 6178905656
- Auditors
- Vitale, Caturano and Company, P.C.
Similar to PMDL
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
As of Today at 18:16 UTC, shares in Pace Medical are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Pace Medical last closed at $0.00 and the price had moved by -23.81% over the past 365 days. In terms of relative price strength the Pace Medical share price has underperformed the S&P500 Index by -31.06% over the past year.
There is no consensus recommendation for this security.
Find out morePace Medical does not currently pay a dividend.
Pace Medical does not currently pay a dividend.
Pace Medical does not currently pay a dividend.
To buy shares in Pace Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Pace Medical had a market capitalisation of .
Here are the trading details for Pace Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PMDL
Based on an overall assessment of its quality, value and momentum Pace Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pace Medical. Over the past six months, its share price has underperformed the S&P500 Index by -89.08%.
As of the last closing price of $0.00, shares in Pace Medical were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pace Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pace Medical's management team is headed by:
- Ralph Hanson - CHM
- Steven Hanson - CEO
- Drusilla Hays - VPR
- Derrick Ebden - DRC
- George Harrington - DRC